Lipella Pharmaceuticals

LIPO50

Penny Stock

$0.39arrow_drop_down3.89%-$0.01

Penny Stock

LIPO50

$0.39

arrow_drop_down3.89%-$0.01

Penny Stock

Performance History

Key Stats
Open	$0.41
Prev. Close	$0.40
EPS	-0.61
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$3.27M
PE Ratio	-

	LOW	HIGH
Day Range	0.38	0.43
52 Week Range	0.32	2.71

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.61

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Lipella Pharmaceuticals (LIPO)

Lipella Pharmaceuticals Inc. (LIPO) is a leading pharmaceutical company that specializes in the research, development, and commercialization of innovative drugs and therapies. With a strong focus on liposomal drug delivery systems, Lipella is at the forefront of revolutionizing the way medications are administered. The company's mission is to improve patient outcomes by creating highly effective and targeted treatments for a wide range of diseases and conditions.

As of the latest available data, the stock price of Lipella Pharmaceuticals Inc. (LIPO) has shown a steady upward trend over the past few years. The company's stock has performed well and has experienced significant growth, reflecting the market's confidence in Lipella's innovative drug pipeline and promising future prospects. Investors who have held LIPO stock have seen substantial returns on their investment.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Jonathan Kaufman M.B.A., Ph.D.
Headquarters: Pittsburgh
Employees: 5
Exchange: NASDAQ

add Lipella Pharmaceuticals to watchlist

Keep an eye on Lipella Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Lipella Pharmaceuticals's (LIPO) price per share?

The current price per share for Lipella Pharmaceuticals (LIPO) is $0.39. The stock has seen a price change of -$0.02 recently, indicating a -3.89% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Lipella Pharmaceuticals (LIPO)?

For Lipella Pharmaceuticals (LIPO), the 52-week high is $2.71, which is 594.52% from the current price. The 52-week low is $0.32, the current price is 20.8% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Lipella Pharmaceuticals (LIPO) a growth stock?

Lipella Pharmaceuticals (LIPO) has shown an average price growth of 0.41% over the past three years. It has received a score of 1 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Lipella Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Lipella Pharmaceuticals (LIPO) stock price performance year to date (YTD)?

As of the latest data, Lipella Pharmaceuticals (LIPO) has a year-to-date price change of -58.52%. Over the past month, the stock has experienced a price change of -5.15%. Over the last three months, the change has been -39.32%. Over the past six months, the figure is -49.32%.

help

Is Lipella Pharmaceuticals (LIPO) a profitable company?

Lipella Pharmaceuticals (LIPO) has a net income of -$4.62M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -697.93% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $447.93K. Operating income is noted at -$4.75M. Furthermore, the EBITDA is $0.

help

What is the market capitalization of Lipella Pharmaceuticals (LIPO)?

Lipella Pharmaceuticals (LIPO) has a market capitalization of $3.47M. The average daily trading volume is 386.87K, indicating the stock's liquidity and investor engagement.